FindMyRecallSubscribe
Class I: serious health riskOngoing

Hospira Inc., A Pfizer Bupivacaine Hydrochloride Inj Recall

Bupivacaine Hydrochloride Inj

Hospira Inc., A Pfizer Company · Lake Forest, IL

Risk level
Class I
Reported by FDA
Dec 28, 2016
Recall ID
D-0218-2017
Check your lot numberHow we source this data

Summary

Hospira Inc., A Pfizer recalled Bupivacaine Hydrochloride Inj starting Aug 4, 2016. The FDA classified it as Class I (serious health risk) and published enforcement report D-0218-2017 on Dec 28, 2016. Reason: Presence of particulate matter: Confirmed customer report for the presence of particulate matter within a single vial. Status: Ongoing.

Why it was recalled

Presence of particulate matter: Confirmed customer report for the presence of particulate matter within a single vial.

Product description

Bupivacaine Hydrochloride Inj., USP (2.5 mg/mL) 0.25%, packaged in 30 mL Single-dose Preservative-Free vials, Rx Only, Hospira, Inc., Lake Forest, IL 60045, NDC 0409-1159-02

Lot numbers, UPCs & expiration codes

Lot # 59064DK, Exp. 11/17

Where it was sold

Nationwide

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0218-2017
Classification
Class I
Status
Ongoing
Recall initiated
Aug 4, 2016
FDA report date
Dec 28, 2016
Quantity
143,250 vials
Recall type
Voluntary: Firm initiated
Recalling firm
Hospira Inc., A Pfizer Company

Original FDA data

Every field from FDA enforcement report D-0218-2017, exactly as published.

Show all FDA fields
City
Lake Forest
State
IL
Status
Ongoing
Country
United States
Event ID
74925
Address
275 N Field Dr
Code information
Lot # 59064DK, Exp. 11/17
Postal code
60045-2579
Report date
Dec 28, 2016
Product type
Drugs
Recall number
D-0218-2017
Classification
Class I
Recalling firm
Hospira Inc., A Pfizer Company
Product quantity
143,250 vials
Reason for recall
Presence of particulate matter: Confirmed customer report for the presence of particulate matter within a single vial.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Bupivacaine Hydrochloride Inj., USP (2.5 mg/mL) 0.25%, packaged in 30 mL Single-dose Preservative-Free vials, Rx Only, Hospira, Inc., Lake Forest, IL 60045, NDC 0409-1159-02
Distribution pattern
Nationwide
Recall initiation date
Aug 4, 2016
Initial firm notification
Letter
Center classification date
Dec 22, 2016

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0218-2017, published Dec 28, 2016. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls